Citation Tools
PDFRegular and Young Investigator Award Abstracts
Clinical Trial In Progress
679 Characterization of tumor specific CD8+ T cell responses in patients with recurrent/metastatic HPV16-positive head and neck cancer receiving HB-200 monotherapy as second or later line treatment in a phase 1 study
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 679 Characterization of tumor specific CD8+ T cell responses in patients with recurrent/metastatic HPV16-positive head and neck cancer receiving HB-200 monotherapy as second or later line treatment in a phase 1 study